𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The cellular and molecular basis of natural antitumor immunity in renal cell carcinoma patients

✍ Scribed by Dolores J. Schendel; C. S. Falk; B. Frankenberger; E. Noessner; J. Schleypen; H. Pohla


Publisher
Springer
Year
2004
Tongue
German
Weight
341 KB
Volume
43
Category
Article
ISSN
0340-2592

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Analysis of the natural killer mediated
✍ Asma Gati; Sylvie Da Rocha; Nadia Guerra; Bernard Escudier; Alessandro Moretta; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 394 KB πŸ‘ 1 views

## Abstract Metastatic renal cell carcinomas (MRCC) are considered as immunogeneic tumors on the basis of the clinical responses observed in patients treated by IL‐2. However, renal cell carcinoma patients are also characterized by alterations of the immune response that may compromise the immunoth

Prognostic relevance of the mTOR pathway
✍ Allan J. Pantuck; David B. Seligson; Tobias Klatte; Hong Yu; John T. Leppert; La πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 980 KB

## Abstract ## BACKGROUND. The mammalian target of rapamycin (mTOR) pathway is up‐regulated in many human cancers, and agents targeting the mTOR pathway are in various stages of clinical development. The goal of the study was to evaluate the potential and limitations of targeting the mTOR pathway